Gracey Craig sold $37K of OMDA

Gracey Craig (Chief Accounting Officer) sold 2,083 shares of Omada Health, Inc. (OMDA) at $18.00 on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gracey Craig
Published Jun 24, 2026, 8:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 24, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

This disclosure updates the insider-trading record but does not indicate a new fundamental catalyst (no guidance, deal, litigation, or regulatory action).

02

Market read

Traders may log the sale for sentiment/positioning, but it is unlikely to drive a standalone repricing.

03

What to watch

The sale size and 10b5-1 structure reduce interpretability; without additional context (e.g., multiple concurrent sales, option exercises, or earnings proximity), signal quality is low.

Relevance 2/10Novelty 3/10Timing: Filed 2026-06-24 after-hours; reflects sale executed 2026-06-22.

Background

SEC Form 4 reports an insider transaction by Omada Health’s Chief Accounting Officer, Gracey Craig, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health CFO Gracey Craig sold 2,083 shares in an open-market transaction at $18.00 on 2026-06-22 under a 10b5-1 plan.

Expected impact

Minimal near-term impact; any effect is likely noise unless paired with other disclosures.

Evidence & confidence

The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan and a relatively small dollar amount versus typical OMDA trading/market cap.

Market effects

No clear sector read-through; this is company-specific insider liquidity rather than operational/regulatory change.

None.

None.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with private concerns; traders may watch for clustering of sales around specific events.

Key entities

  • Omada Health, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Gracey Craig

    Chief Accounting Officer who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHigh

Omada Health Earnings Call Signals Strong Growth Ahead

Omada Health (OMDA) reported Q3 revenue of $91M, up 34% YoY, with GAAP net income of $7M vs. a loss last year. Adjusted EBITDA rose to $12M. Management raised 2026 revenue guidance to $344M-$346M and adjusted EBITDA to $32M-$34M, citing strong demand for diabetes and hypertension programs. The company expects Q4 seasonality and GLP-1 coverage uncertainty.

$OMDAMed

What Omada Health (OMDA) Said on Its Q3 Earnings Call

Omada Health (OMDA) expects Q4 revenue to decline due to seasonal factors, with adjusted EBITDA also moderating. The company ended Q3 with $243M in cash and no debt. CEO Sean Duffy will transition to executive chair in 2027, with Shao taking over as CEO. Omada's GLP-1 Care Track showed a 6% average weight loss at 12 weeks, according to peer-reviewed research.

$OMDAMedAI 8/10

Omada Health Inc (OMDA) (Q3 2026) Earnings Call Highlights: Record Revenue, Membership

Omada Health Inc (OMDA) reported record revenue and membership growth in Q3 2026. However, new enrollments are expected to decline in Q4 due to seasonality and tough comparisons. GLP-1 market dynamics and rising healthcare costs create uncertainty for 2027. Adjusted EBITDA is expected to moderate due to increased R&D and staffing. The company aims for 20%+ growth in 2027 through expanding covered lives, improving enrollment rates, and increasing engagement.